Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Oct 25, 2022

BUY
$11.61 - $15.22 $290,250 - $380,500
25,000 New
25,000 $1,000
Q2 2018

Aug 10, 2018

SELL
$13.44 - $17.59 $40,320 - $52,770
-3,000 Closed
0 $0
Q4 2017

Jan 17, 2018

BUY
$11.73 - $14.75 $35,190 - $44,250
3,000
3,000 $3,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.